Tower Capital and Temasek Holdings have joined company founders to submit a bid to take Singapore-listed traditional Chinese medicine firm Eu Yan Sang International private in a deal that values the company at S$269 million (US$196 million).
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?